Biography

David Haerry has been a treatment writer and conference reporter since 1996. He co-authors a database on travel and residency restrictions for people living with HIV, www.hivtravel.org

He is Secretary General for the Swiss Academic Foundation on Education in Infectious Diseases SAFE-ID, a core team member in the Patvocates Network and a member of the Executive Team at the Patient Focused Medicines Development Initiative. He is involved with the European Patients' Academy on Therapeutic Innovation Innovative Medicines Initiative project EUPATI-IMI since 2012. David Haerry has been involved in the working group updating the CIOMS International Ethical Guidelines for Health-Related Research involving Humans published in December 2016. From 2013 to 2016, he co-chaired the Patient and Consumer Working Party at the European Medicines Agency. Since 2019, he is a member of the Executive Committee for Patients focused Medicines Development PFMD.

In Switzerland, David Haerry is the co-chair of the Swissmedic working group for patient and consumer organisations. He is a member of the Zurich Ethics Commission, the ELSIag at the Swiss Personalised Health Network, the Expert Committee on Cancer Screening and a reviewer for scientific research project applications submitted to the Swiss National Fund and to the Swiss Personalised Health Network. He is the founder and Chair of Positive Council Switzerland and he is closely involved with the Swiss Hepatitis Strategy.

David has been involved in HIV and hepatitis C virus (HCV) drug development since 2005, as well as being active in HIV/AIDS-related aspects of regulatory affairs, research ethics, personalised medicine, risk communication, pharmacovigilance, observational studies, biomedical prevention and research. He has co-authored a number of peer reviewed publication in infectious diseases, doctor-patient communication, pharmacovigilance and patient involvement. David has been living with HIV since 1986.